Riskpilot← Back to searchSign inGet full accessARKIDENTA ApS
APSActiveCVR 27930425Storgade 31, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20041 employees
Revenue 2025
DKK -7K
+8% vs 2024
EBITDA margin
100.0%
-8% vs 2024
Equity ratio
-9887.1%
Financial strength
Net profit 2025
DKK -19K
-280% vs 2024
| Revenue | DKK -7K | +8% |
| EBITDA | DKK -7K | -8% |
| Net profit | DKK -19K | -280% |
| Total assets | DKK 4K | -87% |
| Equity | DKK -410K | -5% |
| Employees | 1 | — |
Legal name
ARKIDENTA ApS
CVR number
27930425
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 2004
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af bestyrelsens formand eller af en direktør alene.
Company purpose
Selskabets formål er at yde rådgivning til virksomheder i tandlægebranchen, samt at formidle og koordinere disse virksomheders indkøb af maskiner, udstyr, materialer og hjælpemidler og anden dermed beslægtet virksomhed.
Address
Storgade 31, 2.
Phone
+4563610062
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199 | -46 | -51 | -114 | -62 | -25 | -11 | -9 | -9 | -6 | -6 | -6 | -6 | -7 |
| Staff expenses | -175 | -293 | -139 | -102 | -21 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 25 | -339 | -189 | -216 | -83 | -24 | -11 | -9 | -9 | -6 | -6 | -6 | -6 | -7 |
| Depreciation & amort. | -234 | -260 | -106 | -34 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -210 | -599 | -295 | -250 | -83 | -24 | -11 | -9 | -9 | -6 | -6 | -6 | -6 | -7 |
| Net financials | -77 | -87 | -100 | -114 | 480 | -25 | -22 | -32 | -16 | -16 | -16 | -16 | -16 | -16 |
| Profit before tax | -286 | -687 | -395 | -364 | 397 | -48 | -34 | -41 | -25 | -22 | -22 | -22 | -22 | -23 |
| Tax | 142 | -127 | -57 | -101 | -13 | -2 | -3 | -21 | -18 | -23 | -22 | -25 | -33 | -4 |
| Net profit | -429 | -560 | -338 | -263 | 410 | -46 | -31 | -20 | -7 | 1 | 0 | 3 | 10 | -19 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 477 | 339 | 103 | 113 | 23 | 4 | 3 | 21 | 18 | 23 | 22 | 25 | 33 | 4 |
| Equity | -1.421 | -1.980 | -2.319 | -2.581 | -302 | -348 | -379 | -398 | -406 | -404 | -404 | -401 | -391 | -410 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.898 | 2.319 | 2.422 | 2.694 | 325 | 353 | 382 | 419 | 423 | 427 | 426 | 426 | 424 | 414 |
| Total debt | 1.898 | 2.319 | 2.422 | 2.694 | 325 | 353 | 382 | 419 | 423 | 427 | 426 | 426 | 424 | 414 |
EBITDA margin
-675000.0%
This company
15.8%
Market median
-4272252% vs market
20122025
Equity ratio
-9887.1%
This company
38.2%
Market median
-25982% vs market
20122025
Return on equity
-1856000.0%
This company
18.4%
Market median
-10087057% vs market
20122025
Net profit margin
-1856000.0%
This company
8.1%
Market median
-22913680% vs market
20122025
Asset turnover
-1.63×
This company
1.12×
Market median
-246% vs market
20122025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PL Founder | Founder | 2004 | — | — |
LO Founder | Founder | 2004 | — | — |
TH Founder | Founder | 2004 | — | — |
JB Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2010 | — | — | |
| Chairman | 2008 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Tandlægeholdingselskabet Storgade 29A, Sorø ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tandlægeholdingselskabet Storgade 29A, Sorø ApS
ARKIDENTA ApS Board members of ARKIDENTA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Lembke Gerdes | Founder | 0 companies |
| Lars Oudrup | Founder | 0 companies |
| Thomas Heitmann | Founder | 0 companies |
| Jesper Bach | Management | 0 companies |
| Kasper Bjørn Slavensky | Chairman | 0 companies |
| Henrik Hoeck | Chairman | 0 companies |
| Pia Marianne Vorting | Chairman | 0 companies |
| Poul Heidelbach Foss Michelsen | Board of Directors | 0 companies |
| Lise Gerdes | Board of Directors | 0 companies |
| Jens Henning Elmerkjær | Board of Directors | 0 companies |
| Jane Vallebo Thorngaard Heitmann | Board of Directors | 0 companies |
| Michael Vorting | Board of Directors | 0 companies |
| Nils Henrik Wegener | Chairman | 0 companies |